nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CYP2E1—Nicotine—ulcerative colitis	0.0752	0.0792	CbGbCtD
Brompheniramine—CYP2B6—Nicotine—ulcerative colitis	0.0742	0.0781	CbGbCtD
Brompheniramine—CYP2B6—Cholecalciferol—ulcerative colitis	0.0666	0.07	CbGbCtD
Brompheniramine—CYP2C8—Nicotine—ulcerative colitis	0.0562	0.0591	CbGbCtD
Brompheniramine—CYP3A4—Budesonide—ulcerative colitis	0.0524	0.0551	CbGbCtD
Brompheniramine—CYP2C8—Cholecalciferol—ulcerative colitis	0.0504	0.0531	CbGbCtD
Brompheniramine—CYP2C19—Nicotine—ulcerative colitis	0.0472	0.0496	CbGbCtD
Brompheniramine—CYP2C19—Cholecalciferol—ulcerative colitis	0.0423	0.0445	CbGbCtD
Brompheniramine—CYP2C9—Nicotine—ulcerative colitis	0.0392	0.0413	CbGbCtD
Brompheniramine—CYP2D6—Nicotine—ulcerative colitis	0.0359	0.0377	CbGbCtD
Brompheniramine—CYP2C9—Cholecalciferol—ulcerative colitis	0.0352	0.037	CbGbCtD
Brompheniramine—CYP2C8—Hydrocortisone—ulcerative colitis	0.0351	0.0369	CbGbCtD
Brompheniramine—CYP2D6—Cholecalciferol—ulcerative colitis	0.0322	0.0338	CbGbCtD
Brompheniramine—CYP2C19—Prednisone—ulcerative colitis	0.0293	0.0308	CbGbCtD
Brompheniramine—CYP2E1—Dexamethasone—ulcerative colitis	0.0292	0.0307	CbGbCtD
Brompheniramine—CYP2B6—Dexamethasone—ulcerative colitis	0.0288	0.0303	CbGbCtD
Brompheniramine—CYP3A4—Methylprednisolone—ulcerative colitis	0.0234	0.0246	CbGbCtD
Brompheniramine—CYP3A4—Nicotine—ulcerative colitis	0.0228	0.024	CbGbCtD
Brompheniramine—CYP2C8—Dexamethasone—ulcerative colitis	0.0218	0.023	CbGbCtD
Brompheniramine—CYP3A4—Cholecalciferol—ulcerative colitis	0.0204	0.0215	CbGbCtD
Brompheniramine—CYP2C19—Dexamethasone—ulcerative colitis	0.0183	0.0193	CbGbCtD
Brompheniramine—CYP3A4—Triamcinolone—ulcerative colitis	0.0177	0.0187	CbGbCtD
Brompheniramine—CYP2C9—Dexamethasone—ulcerative colitis	0.0152	0.016	CbGbCtD
Brompheniramine—CYP3A4—Betamethasone—ulcerative colitis	0.0152	0.016	CbGbCtD
Brompheniramine—CYP3A4—Prednisolone—ulcerative colitis	0.015	0.0158	CbGbCtD
Brompheniramine—CYP3A4—Hydrocortisone—ulcerative colitis	0.0142	0.015	CbGbCtD
Brompheniramine—CYP3A4—Prednisone—ulcerative colitis	0.0142	0.0149	CbGbCtD
Brompheniramine—CYP2D6—Dexamethasone—ulcerative colitis	0.0139	0.0146	CbGbCtD
Brompheniramine—CYP3A4—Dexamethasone—ulcerative colitis	0.00885	0.00931	CbGbCtD
Brompheniramine—Mepyramine—SLC22A4—ulcerative colitis	0.00286	0.46	CrCbGaD
Brompheniramine—Mepyramine—SLC22A5—ulcerative colitis	0.00215	0.345	CrCbGaD
Brompheniramine—Diphenhydramine—SLC22A5—ulcerative colitis	0.000786	0.126	CrCbGaD
Brompheniramine—CHRM3—muscle of abdomen—ulcerative colitis	0.000593	0.402	CbGeAlD
Brompheniramine—Diphenhydramine—PTGS1—ulcerative colitis	0.000428	0.0686	CrCbGaD
Brompheniramine—CHRM5—epithelium—ulcerative colitis	0.000126	0.0855	CbGeAlD
Brompheniramine—CHRM3—smooth muscle tissue—ulcerative colitis	6.8e-05	0.0461	CbGeAlD
Brompheniramine—CHRM3—digestive system—ulcerative colitis	5.37e-05	0.0364	CbGeAlD
Brompheniramine—HRH1—epithelium—ulcerative colitis	5.02e-05	0.034	CbGeAlD
Brompheniramine—CYP2C19—digestive system—ulcerative colitis	4.99e-05	0.0338	CbGeAlD
Brompheniramine—HRH1—smooth muscle tissue—ulcerative colitis	4.83e-05	0.0327	CbGeAlD
Brompheniramine—CYP2B6—lymphoid tissue—ulcerative colitis	3.96e-05	0.0268	CbGeAlD
Brompheniramine—CYP2B6—digestive system—ulcerative colitis	3.91e-05	0.0265	CbGeAlD
Brompheniramine—CYP2C9—digestive system—ulcerative colitis	3.87e-05	0.0262	CbGeAlD
Brompheniramine—HRH1—digestive system—ulcerative colitis	3.82e-05	0.0259	CbGeAlD
Brompheniramine—CYP2C19—liver—ulcerative colitis	3.72e-05	0.0252	CbGeAlD
Brompheniramine—CYP2E1—lymphoid tissue—ulcerative colitis	3.71e-05	0.0252	CbGeAlD
Brompheniramine—CYP2E1—digestive system—ulcerative colitis	3.67e-05	0.0248	CbGeAlD
Brompheniramine—CYP2C8—liver—ulcerative colitis	3.25e-05	0.022	CbGeAlD
Brompheniramine—CYP3A4—digestive system—ulcerative colitis	2.95e-05	0.02	CbGeAlD
Brompheniramine—CYP2B6—liver—ulcerative colitis	2.91e-05	0.0197	CbGeAlD
Brompheniramine—CYP2D6—digestive system—ulcerative colitis	2.9e-05	0.0197	CbGeAlD
Brompheniramine—CYP2C9—liver—ulcerative colitis	2.88e-05	0.0195	CbGeAlD
Brompheniramine—CYP2E1—liver—ulcerative colitis	2.73e-05	0.0185	CbGeAlD
Brompheniramine—CYP2C9—Metabolism—DLD—ulcerative colitis	2.31e-05	0.000551	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PTGER4—ulcerative colitis	2.28e-05	0.000543	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—ADRB2—ulcerative colitis	2.27e-05	0.000542	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—ADRB2—ulcerative colitis	2.26e-05	0.00054	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—ADRB2—ulcerative colitis	2.26e-05	0.000539	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—ADRB2—ulcerative colitis	2.23e-05	0.000533	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—TP53—ulcerative colitis	2.22e-05	0.00053	CbGpPWpGaD
Brompheniramine—CYP3A4—liver—ulcerative colitis	2.2e-05	0.0149	CbGeAlD
Brompheniramine—HRH1—Signaling Pathways—CCL20—ulcerative colitis	2.18e-05	0.00052	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—GHRL—ulcerative colitis	2.18e-05	0.000519	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCL20—ulcerative colitis	2.17e-05	0.000518	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCL20—ulcerative colitis	2.16e-05	0.000517	CbGpPWpGaD
Brompheniramine—CYP2D6—liver—ulcerative colitis	2.16e-05	0.0147	CbGeAlD
Brompheniramine—CHRM2—Signaling Pathways—CCL20—ulcerative colitis	2.14e-05	0.000512	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CALM3—ulcerative colitis	2.11e-05	0.000503	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—GHRL—ulcerative colitis	2.08e-05	0.000497	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RIPK2—ulcerative colitis	2.08e-05	0.000495	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—ADRB2—ulcerative colitis	2.06e-05	0.000492	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—ADRB2—ulcerative colitis	2.06e-05	0.000491	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—ADRB2—ulcerative colitis	2.05e-05	0.000489	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GNA12—ulcerative colitis	2.05e-05	0.000489	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GNA12—ulcerative colitis	2.04e-05	0.000487	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GNA12—ulcerative colitis	2.04e-05	0.000486	CbGpPWpGaD
Brompheniramine—CHRM1—Circadian rythm related genes—IL6—ulcerative colitis	2.03e-05	0.000485	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—ADRB2—ulcerative colitis	2.03e-05	0.000484	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CALM3—ulcerative colitis	2.02e-05	0.000482	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GNA12—ulcerative colitis	2.02e-05	0.000481	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RIPK2—ulcerative colitis	1.99e-05	0.000474	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCR2—ulcerative colitis	1.94e-05	0.000464	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—CXCL8—ulcerative colitis	1.94e-05	0.000463	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCR2—ulcerative colitis	1.94e-05	0.000462	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—CXCL8—ulcerative colitis	1.93e-05	0.000462	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.93e-05	0.000461	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCR2—ulcerative colitis	1.93e-05	0.000461	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—CXCL8—ulcerative colitis	1.93e-05	0.00046	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.93e-05	0.00046	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.93e-05	0.00046	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—ADCY5—ulcerative colitis	1.92e-05	0.000459	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	1.92e-05	0.000459	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—ADCY5—ulcerative colitis	1.92e-05	0.000457	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCR2—ulcerative colitis	1.91e-05	0.000456	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—CXCL8—ulcerative colitis	1.91e-05	0.000456	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—ADCY5—ulcerative colitis	1.9e-05	0.000453	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS1—ulcerative colitis	1.88e-05	0.000449	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CCR6—ulcerative colitis	1.83e-05	0.000436	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CCR6—ulcerative colitis	1.82e-05	0.000434	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CCR6—ulcerative colitis	1.81e-05	0.000433	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ADRB2—ulcerative colitis	1.8e-05	0.00043	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CCR6—ulcerative colitis	1.8e-05	0.000429	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—JAK2—ulcerative colitis	1.78e-05	0.000424	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.76e-05	0.000421	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—ADCY5—ulcerative colitis	1.75e-05	0.000418	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—ADCY5—ulcerative colitis	1.74e-05	0.000416	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—ADCY5—ulcerative colitis	1.74e-05	0.000415	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MAML2—ulcerative colitis	1.73e-05	0.000413	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MAML2—ulcerative colitis	1.73e-05	0.000412	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADRB2—ulcerative colitis	1.72e-05	0.000412	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—ADCY5—ulcerative colitis	1.72e-05	0.000411	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MAML2—ulcerative colitis	1.72e-05	0.00041	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MAML2—ulcerative colitis	1.7e-05	0.000407	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—JAK2—ulcerative colitis	1.7e-05	0.000406	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—CALM3—ulcerative colitis	1.69e-05	0.000404	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—CXCL8—ulcerative colitis	1.62e-05	0.000387	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS1—ulcerative colitis	1.62e-05	0.000386	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—JAK2—ulcerative colitis	1.61e-05	0.000385	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTGER4—ulcerative colitis	1.61e-05	0.000384	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTGER4—ulcerative colitis	1.6e-05	0.000382	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTGER4—ulcerative colitis	1.6e-05	0.000381	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS1—ulcerative colitis	1.58e-05	0.000378	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTGER4—ulcerative colitis	1.58e-05	0.000378	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—CXCL8—ulcerative colitis	1.55e-05	0.000371	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—IL2—ulcerative colitis	1.55e-05	0.00037	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—JAK2—ulcerative colitis	1.54e-05	0.000369	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ADCY5—ulcerative colitis	1.53e-05	0.000365	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—DLD—ulcerative colitis	1.52e-05	0.000363	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.5e-05	0.000358	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—IL2—ulcerative colitis	1.48e-05	0.000354	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CXCL8—ulcerative colitis	1.47e-05	0.000351	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—GHRL—ulcerative colitis	1.47e-05	0.000351	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—GHRL—ulcerative colitis	1.47e-05	0.00035	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADCY5—ulcerative colitis	1.46e-05	0.000349	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—GHRL—ulcerative colitis	1.46e-05	0.000349	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CALM3—ulcerative colitis	1.46e-05	0.000348	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—GHRL—ulcerative colitis	1.45e-05	0.000346	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CALM3—ulcerative colitis	1.43e-05	0.000341	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CALM3—ulcerative colitis	1.43e-05	0.00034	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CALM3—ulcerative colitis	1.42e-05	0.000339	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CALM3—ulcerative colitis	1.42e-05	0.000338	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CXCL8—ulcerative colitis	1.41e-05	0.000337	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL2—ulcerative colitis	1.41e-05	0.000336	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RIPK2—ulcerative colitis	1.4e-05	0.000335	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CALM3—ulcerative colitis	1.4e-05	0.000335	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RIPK2—ulcerative colitis	1.4e-05	0.000334	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RIPK2—ulcerative colitis	1.39e-05	0.000333	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RIPK2—ulcerative colitis	1.38e-05	0.00033	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS1—ulcerative colitis	1.37e-05	0.000327	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.35e-05	0.000322	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL2—ulcerative colitis	1.35e-05	0.000322	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.34e-05	0.000319	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ABCB1—ulcerative colitis	1.32e-05	0.000314	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CALM3—ulcerative colitis	1.23e-05	0.000294	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ADCY5—ulcerative colitis	1.23e-05	0.000293	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS1—ulcerative colitis	1.22e-05	0.000292	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.22e-05	0.000291	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADRB2—ulcerative colitis	1.22e-05	0.000291	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADRB2—ulcerative colitis	1.21e-05	0.00029	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADRB2—ulcerative colitis	1.21e-05	0.000289	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.2e-05	0.000287	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—JAK2—ulcerative colitis	1.2e-05	0.000287	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADRB2—ulcerative colitis	1.2e-05	0.000286	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—JAK2—ulcerative colitis	1.2e-05	0.000286	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—JAK2—ulcerative colitis	1.19e-05	0.000285	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—JAK2—ulcerative colitis	1.18e-05	0.000282	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.18e-05	0.000281	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ABCB1—ulcerative colitis	1.13e-05	0.00027	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS1—ulcerative colitis	1.12e-05	0.000268	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS1—ulcerative colitis	1.12e-05	0.000266	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ABCB1—ulcerative colitis	1.11e-05	0.000265	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CALM3—ulcerative colitis	1.1e-05	0.000263	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.1e-05	0.000262	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.1e-05	0.000262	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CXCL8—ulcerative colitis	1.09e-05	0.000261	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—JAK2—ulcerative colitis	1.09e-05	0.00026	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—CXCL8—ulcerative colitis	1.09e-05	0.00026	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—JAK2—ulcerative colitis	1.09e-05	0.00026	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—JAK2—ulcerative colitis	1.08e-05	0.000259	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CXCL8—ulcerative colitis	1.08e-05	0.000258	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—JAK2—ulcerative colitis	1.07e-05	0.000256	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ADCY5—ulcerative colitis	1.06e-05	0.000252	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.05e-05	0.000251	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—IL2—ulcerative colitis	1.05e-05	0.00025	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—IL2—ulcerative colitis	1.04e-05	0.000249	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—IL2—ulcerative colitis	1.04e-05	0.000249	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ADCY5—ulcerative colitis	1.04e-05	0.000247	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADCY5—ulcerative colitis	1.03e-05	0.000247	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—IL2—ulcerative colitis	1.03e-05	0.000246	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADCY5—ulcerative colitis	1.03e-05	0.000246	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADCY5—ulcerative colitis	1.03e-05	0.000245	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADCY5—ulcerative colitis	1.02e-05	0.000243	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CALM3—ulcerative colitis	1.01e-05	0.000242	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CALM3—ulcerative colitis	1e-05	0.00024	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CXCL8—ulcerative colitis	9.96e-06	0.000238	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CXCL8—ulcerative colitis	9.93e-06	0.000237	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—CXCL8—ulcerative colitis	9.9e-06	0.000236	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CXCL8—ulcerative colitis	9.8e-06	0.000234	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.59e-06	0.000229	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ABCB1—ulcerative colitis	9.59e-06	0.000229	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—JAK2—ulcerative colitis	9.53e-06	0.000227	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL2—ulcerative colitis	9.52e-06	0.000227	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL2—ulcerative colitis	9.49e-06	0.000226	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL2—ulcerative colitis	9.46e-06	0.000226	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL2—ulcerative colitis	9.37e-06	0.000224	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RELA—ulcerative colitis	9.23e-06	0.00022	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PPARG—ulcerative colitis	9.16e-06	0.000219	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—JAK2—ulcerative colitis	9.13e-06	0.000218	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ADCY5—ulcerative colitis	8.95e-06	0.000214	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RELA—ulcerative colitis	8.84e-06	0.000211	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CXCL8—ulcerative colitis	8.7e-06	0.000208	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ABCB1—ulcerative colitis	8.56e-06	0.000204	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CXCL8—ulcerative colitis	8.33e-06	0.000199	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL2—ulcerative colitis	8.31e-06	0.000198	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—IL6—ulcerative colitis	8.27e-06	0.000197	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—ALB—ulcerative colitis	8.24e-06	0.000197	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ADCY5—ulcerative colitis	7.99e-06	0.000191	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL2—ulcerative colitis	7.96e-06	0.00019	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—IL6—ulcerative colitis	7.92e-06	0.000189	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PPARG—ulcerative colitis	7.88e-06	0.000188	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ABCB1—ulcerative colitis	7.88e-06	0.000188	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—MMP9—ulcerative colitis	7.87e-06	0.000188	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ABCB1—ulcerative colitis	7.81e-06	0.000186	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—NFKB1—ulcerative colitis	7.78e-06	0.000186	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PPARG—ulcerative colitis	7.72e-06	0.000184	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—MMP9—ulcerative colitis	7.53e-06	0.00018	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—NFKB1—ulcerative colitis	7.45e-06	0.000178	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS1—ulcerative colitis	7.35e-06	0.000176	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ADCY5—ulcerative colitis	7.35e-06	0.000175	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ADCY5—ulcerative colitis	7.28e-06	0.000174	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—PTGS2—ulcerative colitis	7.21e-06	0.000172	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—ALB—ulcerative colitis	7.09e-06	0.000169	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—STAT3—ulcerative colitis	6.99e-06	0.000167	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—ALB—ulcerative colitis	6.94e-06	0.000166	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—STAT3—ulcerative colitis	6.7e-06	0.00016	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PPARG—ulcerative colitis	6.67e-06	0.000159	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CALM3—ulcerative colitis	6.62e-06	0.000158	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TGFB1—ulcerative colitis	6.48e-06	0.000155	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—JAK2—ulcerative colitis	6.45e-06	0.000154	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—JAK2—ulcerative colitis	6.43e-06	0.000153	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—JAK2—ulcerative colitis	6.41e-06	0.000153	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—JAK2—ulcerative colitis	6.34e-06	0.000151	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RELA—ulcerative colitis	6.24e-06	0.000149	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RELA—ulcerative colitis	6.22e-06	0.000149	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TGFB1—ulcerative colitis	6.21e-06	0.000148	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RELA—ulcerative colitis	6.2e-06	0.000148	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—PTGS2—ulcerative colitis	6.2e-06	0.000148	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RELA—ulcerative colitis	6.14e-06	0.000147	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—PTGS2—ulcerative colitis	6.07e-06	0.000145	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—ALB—ulcerative colitis	6e-06	0.000143	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PPARG—ulcerative colitis	5.96e-06	0.000142	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CXCL8—ulcerative colitis	5.88e-06	0.00014	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CXCL8—ulcerative colitis	5.86e-06	0.00014	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—CXCL8—ulcerative colitis	5.85e-06	0.00014	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CXCL8—ulcerative colitis	5.79e-06	0.000138	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL2—ulcerative colitis	5.62e-06	0.000134	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL2—ulcerative colitis	5.6e-06	0.000134	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—IL6—ulcerative colitis	5.59e-06	0.000134	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL2—ulcerative colitis	5.59e-06	0.000133	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—IL6—ulcerative colitis	5.58e-06	0.000133	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—IL6—ulcerative colitis	5.56e-06	0.000133	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL2—ulcerative colitis	5.53e-06	0.000132	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—IL6—ulcerative colitis	5.5e-06	0.000131	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PPARG—ulcerative colitis	5.48e-06	0.000131	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PPARG—ulcerative colitis	5.43e-06	0.00013	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—ALB—ulcerative colitis	5.36e-06	0.000128	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—TP53—ulcerative colitis	5.34e-06	0.000127	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—MMP9—ulcerative colitis	5.32e-06	0.000127	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—MMP9—ulcerative colitis	5.3e-06	0.000127	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—MMP9—ulcerative colitis	5.29e-06	0.000126	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—NFKB1—ulcerative colitis	5.26e-06	0.000126	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—PTGS2—ulcerative colitis	5.25e-06	0.000125	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—NFKB1—ulcerative colitis	5.25e-06	0.000125	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—MMP9—ulcerative colitis	5.24e-06	0.000125	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—NFKB1—ulcerative colitis	5.23e-06	0.000125	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—NFKB1—ulcerative colitis	5.18e-06	0.000124	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ABCB1—ulcerative colitis	5.15e-06	0.000123	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—TP53—ulcerative colitis	5.11e-06	0.000122	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—ALB—ulcerative colitis	4.93e-06	0.000118	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—IL6—ulcerative colitis	4.89e-06	0.000117	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—ALB—ulcerative colitis	4.88e-06	0.000117	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.8e-06	0.000115	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—STAT3—ulcerative colitis	4.73e-06	0.000113	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—STAT3—ulcerative colitis	4.72e-06	0.000113	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—STAT3—ulcerative colitis	4.7e-06	0.000112	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—PTGS2—ulcerative colitis	4.69e-06	0.000112	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—IL6—ulcerative colitis	4.68e-06	0.000112	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—STAT3—ulcerative colitis	4.66e-06	0.000111	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TGFB1—ulcerative colitis	4.39e-06	0.000105	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TGFB1—ulcerative colitis	4.37e-06	0.000104	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TGFB1—ulcerative colitis	4.36e-06	0.000104	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TGFB1—ulcerative colitis	4.32e-06	0.000103	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—PTGS2—ulcerative colitis	4.31e-06	0.000103	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—PTGS2—ulcerative colitis	4.27e-06	0.000102	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—TP53—ulcerative colitis	3.61e-06	8.62e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—TP53—ulcerative colitis	3.6e-06	8.59e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—TP53—ulcerative colitis	3.59e-06	8.56e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.58e-06	8.55e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—TP53—ulcerative colitis	3.55e-06	8.48e-05	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—IL6—ulcerative colitis	3.3e-06	7.89e-05	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—IL6—ulcerative colitis	3.29e-06	7.86e-05	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—IL6—ulcerative colitis	3.28e-06	7.84e-05	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—IL6—ulcerative colitis	3.25e-06	7.76e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—ALB—ulcerative colitis	3.22e-06	7.69e-05	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.82e-06	6.73e-05	CbGpPWpGaD
